Inventor · disambiguated record
Brendan Bulik-Sullivan
Also filed as: BULIK-SULLIVAN BRENDAN
6 granted patents·18 pending applications·26 citations·filing 2016–2025
77Inventor score
Top patents by PatentIndex Score
24 records- 0193US11183286B2Neoantigen identification, manufacture, and useGRITSTONE BIO INC·Filed 2020·Granted Nov 23, 2021·3 cites·30 claims
- 0291US10055540B2Neoantigen identification, manufacture, and useGRITSTONE ONCOLOGY INC·Filed 2017·Granted Aug 21, 2018·21 cites·25 claims
- 0381US11264117B2Neoantigen identification using hotspotsGRITSTONE BIO INC·Filed 2019·Granted Mar 1, 2022·2 cites·29 claims
- 0473US2024361335A1Reducing junction epitope presentation for neoantigensGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 0571US2024067985A1Viral delivery of neoantigensGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 0669US2025316334A1Neoantigen identification, manufacture, and useGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 0768US2023382997A1Antigen-binding proteins targeting shared antigensGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 0868US2025270589A1Viral delivery of neoantigensSEATTLE PROJECT CORP·Filed 2025·Application pending·0 cites
- 0966US10847253B2Neoantigen identification, manufacture, and useGRITSTONE ONCOLOGY INC·Filed 2018·Granted Nov 24, 2020·0 cites·30 claims
- 1066US2022148681A1Neoantigen identification using hotspotsGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 1165US10847252B2Neoantigen identification, manufacture, and useGRITSTONE ONCOLOGY INC·Filed 2018·Granted Nov 24, 2020·0 cites·31 claims
- 1260US2019034585A1Neoantigen identification, manufacture, and useGRITSTONE ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 1359US11885815B2Reducing junction epitope presentation for neoantigensGRITSTONE BIO INC·Filed 2018·Granted Jan 30, 2024·0 cites·9 claims
- 1458US2023020089A1Shared neoantigen vaccinesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 1555US2017199961A1Neoantigen Identification, Manufacture, and UseGRITSTONE ONCOLOGY INC·Filed 2016·Application pending·0 cites
- 1654US2021113673A1Neoantigen Identification, Manufacture, and UseGRITSTONE ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 1752US2021147550A1Antigen-binding proteins targeting shared antigensFRANCIS JOSHUA MICHAEL·Filed 2018·Application pending·0 cites
- 1848US2020010849A1Viral delivery of neoantigensGRITSTONE ONCOLOGY INC·Filed 2017·Application pending·0 cites
- 1947US2021196806A1Shared antigensGRITSTONE ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 2042US2020411135A1Neoantigen Identification with Pan-Allele ModelsGRITSTONE ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 2141US2022154281A1Identification of neoantigens with mhc class ii modelGRITSTONE BIO INC·Filed 2020·Application pending·0 cites
- 2240US2020105377A1Neoantigen identification, manufacture, and useGRITSTONE ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 2338US2021061914A1Antigen-Binding Proteins Targeting Shared AntigensGRITSTONE ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 2433US2020363414A1Neoantigen Identification for T-Cell TherapyGRITSTONE ONCOLOGY INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brendan Bulik-Sullivan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →